Abacus Life, Inc. Files 8-K on Financials
Ticker: ABXL · Form: 8-K · Filed: Oct 22, 2024 · CIK: 1814287
Sentiment: neutral
Topics: financial-reporting, 8-K, company-update
TL;DR
Abacus Life dropped its 8-K on Oct 22, 2024, with financial updates.
AI Summary
On October 22, 2024, Abacus Life, Inc. filed an 8-K report detailing its financial results and condition. The filing includes financial statements and exhibits, providing an update on the company's operational and financial standing for the period ending October 22, 2024.
Why It Matters
This filing provides investors with crucial, up-to-date information on Abacus Life's financial performance and operational status, enabling informed investment decisions.
Risk Assessment
Risk Level: low — This is a routine financial filing (8-K) and does not appear to contain any immediately alarming or significant new risks.
Key Players & Entities
- Abacus Life, Inc. (company) — Registrant
- October 22, 2024 (date) — Date of earliest event reported
- 2101 Park Center Drive, Suite 200 Orlando, Florida 32835 (address) — Business and Mail Address
- 001-39403 (company_id) — Commission File Number
- 85-1210472 (company_id) — I.R.S. Employer Identification Number
FAQ
What specific financial information is being reported in this 8-K filing?
The filing indicates it contains information regarding 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits'.
What is the exact date of the earliest event reported in this filing?
The date of the earliest event reported is October 22, 2024.
What is the principal business address of Abacus Life, Inc.?
The principal business address is 2101 Park Center Drive, Suite 200, Orlando, Florida 32835.
Under which section of the Securities Exchange Act is this report filed?
This report is filed pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934.
What was Abacus Life, Inc.'s former company name?
The former company name was East Resources Acquisition Co.
Filing Stats: 786 words · 3 min read · ~3 pages · Grade level 12.5 · Accepted 2024-10-22 08:29:05
Key Financial Figures
- $0.0001 — ich registered Common stock, par value $0.0001 per share ABL The NASDAQ Stock Market L
- $11.50 — of common stock at an exercise price of $11.50 per share ABLLW The NASDAQ Stock Market
Filing Documents
- abl-20241022.htm (8-K) — 31KB
- exhibit991_q32024xoctober2.htm (EX-99.1) — 22KB
- imagea.jpg (GRAPHIC) — 29KB
- 0001814287-24-000052.txt ( ) — 271KB
- abl-20241022.xsd (EX-101.SCH) — 3KB
- abl-20241022_def.xml (EX-101.DEF) — 16KB
- abl-20241022_lab.xml (EX-101.LAB) — 28KB
- abl-20241022_pre.xml (EX-101.PRE) — 17KB
- abl-20241022_htm.xml (XML) — 5KB
02. Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition On October 22, 2024, Abacus Life, Inc. (Abacus or Company) issued a press release announcing preliminary financial results for the quarter ended September 30, 2024. A copy of the press release is being furnished as Exhibit 99.1 to this Current Report and incorporated herein by reference. The information in this Item 2.02, including Exhibit 99.1, is being furnished and shall not be deemed "filed" with the U.S. Securities and Exchange Commission or otherwise incorporated by reference into any registration statement or other document filed pursuant to the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.
01. Financial Statement and Exhibits
Item 9.01. Financial Statement and Exhibits. (d) Exhibits. Exhibit Number Exhibit Description 99.1 Press Release, dated October 22, 2024, announcing preliminary financial results for the quarter ended September 30 2024. 104 Cover Page Interactive Data File (formatted as inline XBRL).
Forward Looking Statements
Forward Looking Statements This Current Report on Form 8-K and certain of the materials furnished or filed herewith contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including, without limitation, statements regarding Abacus' public offering. The words "may," "will," "could," "would," "should," "expect," "plan," "anticipate," "intend," "believe," "estimate," "predict," "project," "potential," "continue," "target" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Any forward-looking statements, are based on management's current expectations and beliefs and are subject to a number of risks, uncertainties and important factors that may cause actual events or results to differ materially from those expressed or implied by any forward-looking statements. These and other risks and uncertainties are described in greater detail in the section entitled "Risk Factors" in Abacus' most recent annual report on Form 10-K, as amended, and quarterly report on Form 10-Q filed with the SEC, as well as discussions of potential risks, uncertainties, and other important factors in Abacus' other filings with the SEC, including those contained in the final prospectus and accompanying prospectus related to the public offering filed with the SEC. Any forward-looking statements represent Abacus' views only as of the date hereof and should not be relied upon as representing its views as of any subsequent date. Abacus explicitly disclaims any obligation to update any forward-looking statements, except as required by law.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Abacus Life, Inc. (Registrant) Date: October 22, 2024 By: /s/ Jay Jackson Name: Jay Jackson Title: Chief Executive Officer